bmy

The last time I was on a Cafepharma message board, was when I worked at BMS. Not that I expect a lot of positive comments from anyone on this site, but seriously what is going on? BMS was always a great place to be a rep. I was displaced during an Orencia restructuring and was not even that...

In the third quarter, even as revenue jumped 7%, net earnings came crashing down by about 30%. Even their safely adjusted EPS fell 3%. It's been an up-and-down kind of year for Bristol-Myers Squibb. Early this year, we investors were concerned after BMY opted not to pursue accelerated approval...